Maria Teresa Di Martino
Maria Teresa Di Martino
Bestätigte E-Mail-Adresse bei unicz.it
Titel
Zitiert von
Zitiert von
Jahr
Mir-34: a new weapon against cancer?
G Misso, MT Di Martino, G De Rosa, AA Farooqi, A Lombardi, V Campani, ...
Molecular therapy-nucleic acids 3, e195, 2014
4492014
Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence
MT Di Martino, E Leone, N Amodio, U Foresta, M Lionetti, MR Pitari, ...
Clinical cancer research 18 (22), 6260-6270, 2012
2122012
miR‐29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma‐related bone disease
M Rossi, MR Pitari, N Amodio, MT Di Martino, F Conforti, E Leone, C Botta, ...
Journal of cellular physiology 228 (7), 1506-1515, 2013
1712013
Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth
E Leone, E Morelli, MT Di Martino, N Amodio, U Foresta, A Gullà, M Rossi, ...
Clinical Cancer Research 19 (8), 2096-2106, 2013
1672013
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1
N Amodio, MT Di Martino, U Foresta, E Leone, M Lionetti, M Leotta, ...
Cell death & disease 3 (11), e436-e436, 2012
1602012
Antibacterial activity of Oregano, Rosmarinus and Thymus essential oils against Staphylococcus aureus and Listeria monocytogenes in beef meatballs
G Pesavento, C Calonico, AR Bilia, M Barnabei, F Calesini, R Addona, ...
Food Control 54, 188-199, 2015
1582015
DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma
N Amodio, M Leotta, D Bellizzi, MT Di Martino, P D'Aquila, M Lionetti, ...
Oncotarget 3 (10), 1246, 2012
1442012
In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma
MT Di Martino, A Gullà, MEG Cantafio, M Lionetti, E Leone, N Amodio, ...
Oncotarget 4 (2), 242, 2013
1342013
In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma
MT Di Martino, V Campani, G Misso, MEG Cantafio, A Gulla, U Foresta, ...
PloS one 9 (2), e90005, 2014
1102014
A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells
T Calimeri, E Battista, F Conforti, P Neri, MT Di Martino, M Rossi, ...
Leukemia 25 (4), 707-711, 2011
1092011
Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo
P Tassone, MT Di Martino, M Ventura, A Pietragalla, I Cucinotto, ...
Cancer biology & therapy 8 (7), 648-653, 2009
1022009
miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells
N Amodio, D Bellizzi, M Leotta, L Raimondi, L Biamonte, P D’Aquila, ...
Cell Cycle 12 (23), 3650-3662, 2013
1002013
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity
L Raimondi, N Amodio, MT Di Martino, E Altomare, M Leotta, ...
Oncotarget 5 (10), 3039, 2014
912014
Promises and challenges of MicroRNA-based treatment of multiple myeloma
P Tagliaferri, M Rossi, M T Di Martino, N Amodio, E Leone, A Gulla, A Neri, ...
Current cancer drug targets 12 (7), 838-846, 2012
902012
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo
E Morelli, E Leone, MEG Cantafio, MT Di Martino, N Amodio, L Biamonte, ...
Leukemia 29 (11), 2173-2183, 2015
882015
A p53‐dependent tumor suppressor network is induced by selective miR‐125a‐5p inhibition in multiple myeloma cells
M Leotta, L Biamonte, L Raimondi, D Ronchetti, MT Di Martino, C Botta, ...
Journal of cellular physiology 229 (12), 2106-2116, 2014
882014
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells
MT Di Martino, A Gullà, MEG Cantafio, E Altomare, N Amodio, E Leone, ...
PloS one 9 (2), e89659, 2014
862014
Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia
M Lionetti, P Musto, MT Di Martino, S Fabris, L Agnelli, K Todoerti, ...
Clinical cancer research 19 (12), 3130-3142, 2013
862013
Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMET …
MT Di Martino, M Arbitrio, E Leone, PH Guzzi, M Saveria Rotundo, ...
Cancer biology & therapy 12 (9), 780-787, 2011
852011
A 13 mer LNA-i-miR-221 inhibitor restores drug sensitivity in melphalan-refractory multiple myeloma cells
A Gullà, MT Di Martino, MEG Cantafio, E Morelli, N Amodio, C Botta, ...
Clinical cancer research 22 (5), 1222-1233, 2016
822016
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20